Combined Effect of Midazolam and Bone Morphogenetic Protein-2 for Differentiation Induction from C2C12 Myoblast Cells to Osteoblasts

In drug repositioning research, a new concept in drug discovery and new therapeutic opportunities have been identified for existing drugs. Midazolam (MDZ) is an anesthetic inducer used for general anesthesia. Here, we demonstrate the combined effects of bone morphogenetic protein-2 (BMP-2) and MDZ o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidaka, Yukihiko, Chiba-Ohkuma, Risako, Karakida, Takeo, Onuma, Kazuo, Yamamoto, Ryuji, Fujii-Abe, Keiko, Saito, Mari M., Yamakoshi, Yasuo, Kawahara, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150865/
https://www.ncbi.nlm.nih.gov/pubmed/32131534
http://dx.doi.org/10.3390/pharmaceutics12030218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150865/
https://www.ncbi.nlm.nih.gov/pubmed/32131534
http://dx.doi.org/10.3390/pharmaceutics12030218

Ejemplares similares